Clinical Study of Huaier Granule in the Treatment of Unresectable Pancreatic Cancer
Status:
NOT_YET_RECRUITING
Trial end date:
2028-08-01
Target enrollment:
Participant gender:
Summary
This is a prospective, multicenter, randomized, open, parallel controlled clinical study to evaluate the efficacy and safety of Huaier Granules combined with capecitabine in the treatment of unresectable pancreatic cancer.
Phase:
PHASE4
Details
Lead Sponsor:
Xi'an Jiaotong University
Collaborators:
Huazhong University of Science and Technology LinkDoc Technology (Beijing) Co. Ltd.